Matrix metalloproteinase inhibitors 1998

Expert Opinion on Therapeutic Patents

Volumn 8, Issue 3, 1998, Pages 259-282

  Beckett, R P ^a   Whittaker, M ^a  

^a British Biotech Pharmaceuticals Ltd   (United Kingdom)

Author keywords

Arthritis; Cancer; Collagenase; Gelatinase; Matrix metalloproteinase; Stromelysin; Tumour necrosis factor

Indexed keywords

4 [[[4 (4 CHLOROPHENOXY)PHENYL]SULFONYL]METHYL]TETRAHYDRO 2H PYRAN 4 CARBOHYDROXAMIC ACID; BAY 12 9556; CGS 27023A; COLLAGENASE; D 1927; D 5410; GELATINASE; HYDROXAMIC ACID DERIVATIVE; MARIMASTAT; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE INHIBITOR; PRINOMASTAT; REBIMASTAT; RO 32 9555; SOLIMASTAT; STROMELYSIN; UNCLASSIFIED DRUG;

DRUG DESIGN; DRUG EFFICACY; DRUG INDUSTRY; ENZYME INHIBITION; HUMAN; REVIEW; STRUCTURE ACTIVITY RELATION;

EID: 0031906807     PISSN: 13543776     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543776.8.3.259     Document Type: Review

References (84)